![]() |
USP-NF General NoticesDecember 21, 2007USP is proposing to revise the General Notices of the United States Pharmacopeia and National Formulary. View the proposed General Notices revisions The proposed changes are being published in Pharmacopeial Forum 34(1) (Jan. - Feb. 2008) and are open for public comment until April 15, 2008. Comments on the proposal may be submitted via email to or to: Executive Secretariat The General Notices are key resources for users of the compendia, but have not been updated in a number of years and have seen an accretion of information over time. USP is taking this opportunity to re-organize and streamline the General Notices to make them more readable and easier to use. The proposed changes to General Notices would:
CrosswalksIn addition to the revised General Notices, USP also will provide "crosswalk" documents showing current USP and NF text side-by-side with the proposed text for easy comparison. Check back soon for these documents. Revision ProcessThe draft presented here and in PF 34(1) is the second draft of the revised General Notices. The first draft was made available on this Web site in May 2007 and was available for public comment until August 31, 2007. Numerous comments were received, carefully considered, and incorporated as appropriate into this second draft. Brief summaries of many of the comments received, and USP's responses to the comments, including requests for additional input, are included in an Explanatory Note USP plans to present comments received on the second draft, with proposed resolutions for the issues raised in the comments, to the Council of Experts Executive Committee in the late spring of 2008 for their consideration and approval. The proposed revised General Notices are targeted for publication in USP and NF as official in USP 32-NF 27 (November 2008). Topics for Continuing DialogueAs a result of comments received, USP has decided to continue conversations in 2008 on a number of topics that would have a significant impact on the compendia and their users. Following these discussions, additional changes to the General Notices may be proposed later in 2008, in a second phase of the revision process. Those changes would not become official before USP 33-NF 28 (November 2009). Topics that were covered in the first draft of the revised General Notices but are not included in this second draft and are pending additional dialogue include:
More information about the changes that were proposed in the first draft that are still under consideration is available here. |
|||||
Copyright © 2008 The United States Pharmacopeial Convention
|
|||||